2025 annual financial data
Cellyan Biotechnology 2025 Financial results
Direct answer
Revenue was 20,313,818 USD.
Operating income was 132,038 USD and net income was -27,056 USD.
Operating cash flow was 569,214 USD.
Get free Cellyan Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,313,818 USD
- Operating income
- 132,038 USD
- Net income
- -27,056 USD
- Operating cash flow
- 569,214 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Cellyan Biotechnology financial years